Agilent Technologies (A) A Q4 Financial Results Summary
QuoteReporter
Agilent Technologies, Inc. (A) Q4 2025 Financial Results Summary
On November 24, 2025, Agilent Technologies, Inc. released its fourth-quarter financial results for the fiscal year 2025, showcasing solid performance and providing guidance for fiscal year 2026.
Key Financial Highlights
- Revenue
- Q4 2025: $1.86 billion, an increase of 9.4% (reported) and 7.2% (core) compared to Q4 2024.
-
Full Fiscal Year 2025: $6.95 billion, a growth of 6.7% (reported) and 4.9% (core) compared to fiscal year 2024.
-
Net Income
- Q4 2025: GAAP net income of $434 million; EPS of $1.53, reflecting a growth of 25% compared to Q4 2024.
-
Non-GAAP net income for Q4 2025: $452 million; Non-GAAP EPS of $1.59, up 9% from the same quarter last year.
-
Full Fiscal Year 2025 Net Income
- GAAP net income: $1.303 billion; EPS of $4.57, up 3% year-over-year.
- Non-GAAP net income: $1.592 billion; Non-GAAP EPS: $5.59, up 6% compared to fiscal year 2024.
Revenue from Business Segments (Q4 2025 vs. Q4 2024)
- Life Sciences and Diagnostics Markets Group
- Revenue of $755 million, a growth of 15% (reported) and 11% (core) year-over-year.
-
Operating margin: 22.7%.
-
Agilent CrossLab Group
- Revenue of $755 million, an increase of 7% (reported) and 6% (core) compared to the prior year.
-
Operating margin: 32.5%.
-
Applied Markets Group
- Revenue of $351 million, an increase of 4% (reported) and 3% (core).
- Operating margin: 24.7%.
Full Year 2026 and Q1 Outlook
- Fiscal Year 2026 Guidance
- Expected revenue: Between $7.3 billion and $7.4 billion, representing growth of 5% to 7% (reported) and 4% to 6% (core).
-
Non-GAAP EPS anticipated in the range of $5.86 to $6.00.
-
First Quarter 2026 Guidance
- Expected revenue: Between $1.79 billion and $1.82 billion, a growth of 6% to 8% (reported) and 4% to 6% (core).
- Non-GAAP EPS expected in the range of $1.35 to $1.38 per share.
Other Financial Metrics
- Total costs and expenses in Q4 2025 amounted to $1.418 billion, up from $1.293 billion in Q4 2024.
- Cash flows from operating activities totaled $1.303 billion for the year ended October 31, 2025, compared to $1.289 billion in the previous year.
Shareholder Returns
Agilent declared a quarterly dividend payment of $282 million, compared to $274 million in the previous year, showing an increase in shareholder returns.
Additionally, during the fourth quarter, Agilent repurchased $425 million of its common stock, highlighting the company’s commitment to returning value to its shareholders.
Executive Statements
Padraig McDonnell, President and CEO of Agilent, remarked, “We enter FY26 with confidence and momentum. Agilent is uniquely positioned to lead in life-sciences and diagnostics for years to come.” This statement signifies the company’s robust strategic positioning moving forward.
Conclusion
Agilent Technologies, Inc. delivered solid financial results for the fourth quarter of fiscal year 2025, including revenue and earnings growth compared to the prior year. The company anticipates continued growth and is positioning itself strongly for fiscal year 2026, underpinned by solid performances across its business segments and proactive measures to enhance shareholder value.
| Years Ended | Years Ended | October 31, 2025 | October 31, 2024 | October 31, 2025 | October 31, 2024 |
|---|---|---|---|---|---|
| Net revenue | $1,861 | $1,701 | $6,948 | $6,510 | |
| Costs and expenses: | |||||
| Cost of products and services | 871 | 785 | 3,305 | 2,975 | |
| Research and development | 119 | 111 | 455 | 479 | |
| Selling, general and administrative | 428 | 397 | 1,709 | 1,568 | |
| Total costs and expenses | 1,418 | 1,293 | 5,469 | 5,022 | |
| Income from operations | 443 | 408 | 1,479 | 1,488 | |
| Interest income | 17 | 24 | 62 | 80 | |
| Interest expense | -27 | -32 | -112 | -96 | |
| Other income (expense), net | 9 | 1 | 6 | 49 | |
| Income before taxes | 442 | 401 | 1,435 | 1,521 | |
| Provision for income taxes | 8 | 50 | 132 | 232 | |
| Net income | $434 | $351 | $1,303 | $1,289 | |
| Net income per share: | |||||
| Basic | $1.53 | $1.23 | $4.59 | $4.44 | |
| Diluted | $1.53 | $1.22 | $4.57 | $4.43 | |
| Weighted average shares used in computing net income per share: | |||||
| Basic | 283 | 286 | 284 | 290 | |
| Diluted | 284 | 287 | 285 | 291 |
| October 31, 2025 | October 31, 2024 | |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $1,789 | $1,329 |
| Accounts receivable, net | 1,487 | 1,324 |
| Inventory | 1,025 | 972 |
| Other current assets | 293 | 334 |
| Total current assets | 4,594 | 3,959 |
| Property, plant and equipment, net | 2,023 | 1,778 |
| Goodwill | 4,473 | 4,477 |
| Other intangible assets, net | 445 | 547 |
| Long-term investments | 133 | 175 |
| Other assets | 1,059 | 910 |
| Total assets | $12,727 | $11,846 |
| LIABILITIES AND EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $570 | $540 |
| Employee compensation and benefits | 443 | 368 |
| Deferred revenue | 624 | 544 |
| Short-term debt | 304 | 45 |
| Other accrued liabilities | 406 | 398 |
| Total current liabilities | 2,347 | 1,895 |
| Long-term debt | 3,050 | 3,345 |
| Retirement and post-retirement benefits | 126 | 130 |
| Other long-term liabilities | 463 | 578 |
| Total liabilities | 5,986 | 5,948 |
| Total Equity: | ||
| Stockholders’ equity: | ||
| Preferred stock; $0.01 par value; 125,000,000 shares authorized; none issued and outstanding | ||
| Common stock; $0.01 par value; 2,000,000,000 shares authorized; | ||
| 283,054,377 shares at October 31, 2025 | 3 | 3 |
| and 285,193,011 shares at October 31, 2024, issued and outstanding | ||
| Additional paid-in-capital | 5,575 | 5,450 |
| Retained earnings | 1,389 | 750 |
| Accumulated other comprehensive loss | -226 | -305 |
| Total stockholders’ equity | 6,741 | 5,898 |
| Total liabilities and stockholders’ equity | $12,727 | $11,846 |